Patterson Companies, Inc. (NASDAQ:PDCO) to Post Q3 2025 Earnings of $0.70 Per Share, Leerink Partnrs Forecasts

Patterson Companies, Inc. (NASDAQ:PDCO) – Stock analysts at Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for Patterson Companies in a research note issued on Wednesday, August 28th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $0.70 per share for the quarter, up from their previous forecast of $0.61. The consensus estimate for Patterson Companies’ current full-year earnings is $2.36 per share. Leerink Partnrs also issued estimates for Patterson Companies’ Q4 2025 earnings at $0.90 EPS, FY2025 earnings at $2.33 EPS, FY2026 earnings at $2.54 EPS, FY2027 earnings at $2.81 EPS and FY2028 earnings at $3.09 EPS.

Several other equities analysts have also issued reports on the stock. StockNews.com lowered shares of Patterson Companies from a “buy” rating to a “hold” rating in a report on Saturday, June 1st. Robert W. Baird reduced their target price on Patterson Companies from $30.00 to $28.00 and set a “neutral” rating on the stock in a research report on Thursday. Morgan Stanley decreased their price target on Patterson Companies from $30.00 to $28.00 and set an “equal weight” rating for the company in a research note on Thursday, June 20th. Evercore ISI dropped their price target on Patterson Companies from $25.00 to $23.00 and set an “in-line” rating on the stock in a research note on Thursday. Finally, Bank of America decreased their price objective on shares of Patterson Companies from $31.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $28.89.

Patterson Companies Stock Down 0.0 %

NASDAQ:PDCO opened at $22.47 on Friday. The company’s 50-day simple moving average is $24.57 and its 200-day simple moving average is $25.53. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.75 and a current ratio of 1.33. Patterson Companies has a fifty-two week low of $21.56 and a fifty-two week high of $32.58. The stock has a market capitalization of $1.97 billion, a P/E ratio of 11.23, a P/E/G ratio of 2.32 and a beta of 1.06.

Patterson Companies (NASDAQ:PDCO) last issued its earnings results on Wednesday, August 28th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.08). The business had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.59 billion. Patterson Companies had a return on equity of 20.80% and a net margin of 2.83%. The firm’s revenue was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.40 earnings per share.

Hedge Funds Weigh In On Patterson Companies

Hedge funds have recently made changes to their positions in the company. LRI Investments LLC lifted its stake in shares of Patterson Companies by 201.2% in the second quarter. LRI Investments LLC now owns 1,262 shares of the company’s stock worth $30,000 after buying an additional 843 shares in the last quarter. GAMMA Investing LLC acquired a new stake in Patterson Companies in the 4th quarter valued at about $32,000. Spire Wealth Management purchased a new position in Patterson Companies in the 1st quarter worth approximately $35,000. Mather Group LLC. boosted its holdings in shares of Patterson Companies by 1,376.1% during the 2nd quarter. Mather Group LLC. now owns 1,609 shares of the company’s stock worth $39,000 after purchasing an additional 1,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Patterson Companies in the second quarter valued at approximately $41,000. Institutional investors and hedge funds own 85.43% of the company’s stock.

Insider Transactions at Patterson Companies

In related news, CEO Donald Zurbay sold 5,875 shares of the business’s stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $23.71, for a total value of $139,296.25. Following the completion of the transaction, the chief executive officer now directly owns 237,288 shares in the company, valued at approximately $5,626,098.48. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CEO Donald Zurbay sold 5,875 shares of the company’s stock in a transaction dated Wednesday, July 3rd. The stock was sold at an average price of $23.71, for a total value of $139,296.25. Following the completion of the transaction, the chief executive officer now owns 237,288 shares of the company’s stock, valued at approximately $5,626,098.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Kevin Michael Barry sold 1,216 shares of the firm’s stock in a transaction that occurred on Wednesday, July 3rd. The shares were sold at an average price of $23.72, for a total value of $28,843.52. Following the completion of the sale, the chief financial officer now directly owns 41,605 shares in the company, valued at $986,870.60. The disclosure for this sale can be found here. Insiders have sold 17,149 shares of company stock worth $415,851 over the last quarter. 1.50% of the stock is currently owned by insiders.

Patterson Companies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 2nd. Stockholders of record on Friday, July 19th were issued a $0.26 dividend. The ex-dividend date was Friday, July 19th. This represents a $1.04 annualized dividend and a dividend yield of 4.63%. Patterson Companies’s dividend payout ratio (DPR) is presently 52.00%.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.